Journal of Diabetes & Metabolism

ISSN - 2155-6156


Dr. Subhash Kumar

Diabetes & Obesity Care Centre, India


  • Mini Review   
    Imeglimin: Therapeutic Option for Achieving Glycemic Control
    Author(s): Dr. Subhash Kumar*

    Imeglimin is a new class of drug which has introduced recently. The molecular mechanisms are unknown, although imeglimin improves insulin sensitivity in humans. Pre-clinical studies had confirmed that imeglimin favouring lipid oxidation in liver and preserving mitochondrial function from oxidative stress, therefore normalizes glucose tolerance and insulin sensitivity. The main objective of this review article is to highlight updates of new class of drug which is imeglimin and generated a huge interest after recently conducted EASD at Barcelona... Read More»
    DOI: 10.35248/2155-6156.19.10.838

    Abstract HTML PDF